Sorption of fluoroacetate (compound 1080) by colestipol, activated charcoal and anion-exchange resins in vitro and gastrointestinal decontamination in rats

Veterinary and Human Toxicology

Volumn 42, Issue 5, 2000, Pages 269-275

  Norris, W R ^a   Temple, W A ^a   Eason, C T ^a   Wright, G R ^a   Ataria, J ^a   Wickstrom, M L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIETHYLAMINOETHANOL; ACTIVATED CARBON; ANION EXCHANGE RESIN; BENTONITE; CARBOSORB; CHITOSAN; COLESTIPOL; COLESTYRAMINE; FLUOROACETIC ACID; POLACRILIN; SEPHADEX; SORBENT;

ADSORPTION; ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; GASTROINTESTINAL TRACT; INTESTINE LAVAGE; INTOXICATION; MALE; MORTALITY; NONHUMAN; RAT; STOMACH LAVAGE; TOXICOKINETICS; TREATMENT INDICATION;

ADSORPTION; ANALYSIS OF VARIANCE; ANIMAL; ANION EXCHANGE RESINS; CHARCOAL; COLESTIPOL; FLUOROACETATES; INTESTINES; MALE; RATS; RATS, WISTAR; SUPPORT, NON-U.S. GOV'T;

EID: 0033825663     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (90)

1. Fatal poisoning with sodium fluoroacetate
2. Clinical presentation and prognostic factors in sodium monofluoroacetate intoxication
3. Fluoroacetate poisoning
4. Poisoning due to sodium fluoroacetate ('1080')
5. Subacute fluoroacetate poisoning
6. Sodium fluoroacetate poisoning
7. Computed tomography demonstration of brain damage due to acute sodium monofluoroacetate poisoning
8. Survey of New Zealand veterinarians on their treatment 1080 and metaldehyde poisonings
9. Fluoroacetate poisoning in sheep
10. Studies on the biochemical basis of susceptibility and resistance of the housefly to fluoroacetate
11. The effect of ethanol and various metabolites on fluoroacetate poisoning
12. 13C NMR
13. Clinical, pathological, diagnostic and therapeutic aspects of fluoroacetate research in animals
14. Fluorocitrate and fluoroacetate effects on astrocyte metabolism in vitro
15. Biochemical aspects of fluoroacetate poisoning in isolated rat kidney tubules: Reversibility of inhibition of gluconeogenesis by a-ketoglutarate
16. Evaluation of potential antidotes for sodium fluoroacetate in mice
17. Factors influencing fluoroacetate poisoning. Practical treatment with glycerol monoacetate
18. Short communications. Observations on the use and action of monoacetin in fluoroacetate poisoning
19. The effect of monoacetin and calcium chloride on acid-base balance and survival in experimental sodium fluoroacetate poisoning
20. Fluoroacetamide poisoning in man: The role of ionized calcium
21. Persistence of sodium monofluoroacetate in rabbits and risk to non-target species
22. Inorganic and organic fluoride concentrations in tissues after the oral administration of sodium monofluoroacetate (Compound 1080) to rats
23. 18F]-fluoroacetate in mice
24. Position statement: Ipecac syrup
25. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose
26. Position statement: Gastric lavage
27. Position statement: Single dose activated charcoal
28. Expanded role of charcoal therapy in the poisoned and overdosed patient
29. Adsorption of drugs and poisons by activated charcoal
30. The fate of sodium monofluoroacetate (1080) in water, mammals, and invertebrates
31. Persistence of sodium monofluoroacetate in livestock animals and risk to humans
32. Pharmacokinetics of aspirin and salicylate in elderly subjects and in patients with alcoholic liver disease
33. Effect of activated charcoal on aspirin absorption in man. Part 1
34. Activated charcoal reduces the need for N-Acetylcystein treatment after acetaminophen (paracetamol) overdose
35. In vitro adsorption studies of cimetidine
36. An in vitro evaluation of cocaine hydrochloride adsorption by activated charcoal and desorption upon addition of polyethylene glycol electrolyte lavage solution
37. An in vitro evaluation of fluoxetine adsorption by activated charcoal and desorption upon addition of polyethylene glycol- electrolyte lavage solution
38. Adsorption of fluoxetine HCI by activated charcoal
39. Adsorbent selection for endosulfan removal from water environment
40. Activated charcoal is as effective as fuller's earth or bentonite in paraquat poisoning
41. Studies on in vitro paraquat and diquat removal by activated carbon
42. Adsorption removal of benzalkonium chloride by granular activated carbon for medical waste water treatment
43. Phenobarbital adsorption from simulated intestinal fluid, U.S.P., and simulated gastric fluid, U.S.P., by two activated charcoals
44. Computer modeling of adsorption on an activated charcoal surface
45. Reduction of diazepam serum half life and reversal of coma by activated charcoal in a patient with severe liver disease
46. Transport of the ophylline from blood to the intestinal lumen following i.v. administration to rats
47. Charcoal stercolith with intestinal perforation in a patient treated for amitriptyline ingestion
48. Treatment of hyperlipoproteinaemia type IIa with a new anion exchange resin secholex®
49. Quantification of the binding tendencies of cholestyramine I: Effect of structure and added electrolytes on the binding of unconjugated and conjugated bile-salt anions
50. Equilibrium and kinetic factors influencing bile sequestrant efficacy
51. Polymeric sorbents for bile acids. I: Comparison between cholestyramine and colestipol
52. Effect of pH changes and ethanol on the binding of tricyclic antidepressants to cholestyramine in simulated gastric fluid
53. Cholestyramine as an adsorbent in acute lindane poisoning: A murine model
54. Failure of oral activated charcoal to accelerate the elimination of amiodarone and chloroquine
55. Bile-acid sequestrants and lipid metabolism
56. The potential of mucoadhesive polymers in enhancing intestinal peptide drug absorption. III: Effects of chitosan-glutamate and carbomer on epithelial tight junctions in vitro
57. Adsorption and desorption of indomethacin on cellulose- like biopolymers: Chitin and chitosan
58. Quantification of the binding tendencies of cholestyramine II: Mechanism of interaction with bile salt and fatty acid salt anions
59. Effect of competing anions on binding of bile salts by cholestyramine
60. Drug adsorption onto activated charcoal as a means of formulation
61. Characteristics of barbiturate adsorption on activated charcoal
62. Relationship between effect of activated charcoal on drug absorption in man and its drug absorption characteristics in vitro
63. Cocaine adsorption to activated charcoal in vitro
64. In vitro study of lithium carbonate adsorption by activated charcoal
65. Decomposition of arteether in simulated stomach acid yielding compounds retaining antimalarial activity
66. Microencapsulated Eudragit RS30D-coated controlled-release pellets: The influence of dissolution variables and topographical evaluation
67. The availability 'in vitro' of magnesium formulations using various leaching media
68. Mechanism of drug release from an acrylic polymer-wax matrix tablet
69. Sodium monofluoroacetate (1080) water-residue analysis after large-scale possum control
70. Fluoroacetate content of some species of the toxic Australian plant genus, Gastrolobium, and its environmental persistence
71. Gas chromatographic determination of sodium monofluoroacetate in water by derivatisation with dicyclohexylcarbodiimide
72. Determination of monofluoroacetate in soil and biological samples as the dichloroanilide derivative
73. Binding of bile acids to cholestyramine at gastric pH conditions
74. Effect of anions on adsorption of bile salts by colestipol hydrochloride
75. Potential of organic cation-saturated montmorillonite as treatment for poisoning by weak bases
76. Citrate excretion: A window on renal metabolism
77. Monofluoroacetic acid and related compounds
78. The bile acid binding and hypocholesterolemic action of two water-soluble polymers